CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021
– EBITDA grew 47% for 12 months ended 31 Dec 2021 – Proposed listing of 49%-owned Acumen Diagnostics on NASDAQ
Read More
Aoxin Q&M Dental Group Limited
Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide
– Acumen Diagnostics will implement swabbing and COVID-19 PCR tests via Q&M Dental’s network of outlets to provide accessible, affordable,
Read More